Article Details

Alembic Pharmaceuticals receives USFDA final approval for Ticagrelor Tablets

Retrieved on: 2025-05-03 10:24:19

Tags for this article:

Click the tags to see associated articles and topics

Alembic Pharmaceuticals receives USFDA final approval for Ticagrelor Tablets. View article details on hiswai:

Excerpt

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Brilinta Tablets, 60 mg and 90 mg, of AstraZeneca ...

Article found on: www.capitalmarket.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo